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This study characterized the high molecular mass
BP180 complex that is observed when unheated
sodium dodecyl sulfate extracts of human skin or
keratinocytes are subjected to sodium dodecyl sulfate-
polyacrylamide gel electrophoresis and immuno-
blotting. In heated extracts BP180 is present as a
monomer with a molecular weight of 180 kDa, in
unheated extracts BP180 runs at a molecular weight
position over 500 kDa. By preincubating the unheated
extracts at temperatures between 31°C and 40°C, the
high molecular weight complex could be ‘‘melted’’
down to monomeric BP180. Under the conditions
employed the T1/2 of the dissociation process was
between 35°C and 36°C. The temperature resistance
of the high molecular weight complex was used to
BP180 or type XVII collagen is one of the targetantigens for autoantibody deposition in the blisteringdisease bullous pemphigoid (BP) (Labib et al, 1986).The molecule is a transmembrane protein present inhemidesmosome complexes that connect basal ker-
atinocytes with the underlying extracellular matrix. BP180 is
thought to function as a cell–matrix connector, its ligands, however,
have not yet been identified. The pathogenicity of BP180 antibody
binding has been demonstrated in a passive transfer murine model
in which the presence of BP180-specific antibodies led to a BP-
like blistering disease (Liu et al, 1993). Cloning of the coding
sequence of BP180 has enabled the identification of the major
bullous pemphigoid and herpes gestationes epitopes on the mole-
cule, which seem to cluster in the extracellular membrane-adjacent
NC16a domain (Giudice et al, 1993; Zillikens et al, 1997). A
second epitope cluster, ultrastructurally located further down the
lamina lucida, near the carboxy-terminal part of the molecule, is
recognized by autoantibodies of a subset of patients suffering from
cicatricial pemphigoid (Balding et al, 1996; Bedane et al, 1997).
Except participating as an antigen in autoimmune diseases, BP180
itself is also the target in a group of hereditary blistering disorders.
Mutations in the gene coding for BP180 may lead to incomplete
or absent BP180 and clinically result in generalized atrophic benign
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analyze its molecular composition by performing two-
dimensional electrophoresis with a ‘‘low-temperature’’
first dimension step and a ‘‘high-temperature’’ second
dimension step. Silver staining and immunoblotting of
the two-dimensional gels revealed the high molecular
weight complex to be composed of solely BP180,
indicating that the complex is the nondissociated
homotrimeric form of BP180. The 120 kDa linear
IgA dermatosis antigen (LAD-1) is an collagenous
anchoring filament protein with homology to the
extracellular collagenous part of BP180. Two-dimen-
sional immunoblotting showed that LAD-1, as BP180,
is also present as a high molecular mass complex and
does not form mixed complexes with BP180. Key
words: basement membrane/hemidesmosome/protein struc-
ture/trimer. J Invest Dermatol 112:58–61, 1999
epidermolysis bullosa (Jonkman et al, 1995; McGrath et al, 1996;
Scheffer et al, 1997).
Molecular analysis of the human BP180 amino acid sequence
predicted the molecule to be a type II transmembrane protein with
15 collagen domains located in the extracellular carboxy-terminal
part of the molecule. Together these domains constitute a 87 kDa
collagenous fragment that potentially could form a macromolecular
triple-helix (Giudice et al, 1992). In 1996, Hirako et al showed
that solubilized chemically cross-linked bovine BP180 indeed runs
on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) with a molecular weight suggestive of a homotrimer. By
rotary-shadowing of the purified protein, three distinct shapes
could be identified: a globular head, a central rod, and a flexible
tail. In the globular head three subdomains were recognized that
are believed to represent the individual monomer cytoplasmic
domains. The central rod corresponded in length to the largest
collagen domain (COL15), leaving the flexible tail to consist of
the 14 remaining collagen domains (COL1 to COL14) interrupted
by noncollagenous sequences (Hirako et al, 1996). Balding et al
(1997) showed that the ectodomain of BP180 when overproduced
in COS cells was capable of trimerizing, three monomers combining
to a higher molecular mass complex. The sedimentation constants
of this complex suggested that it had the form of a highly extended
flexible rod, which confirmed the data of Hirako.
In 1997 we described the molecular similarity between the
120 kDa autoantigen, LAD-1, in linear IgA bullous dermatosis and
the extracellular domain of BP180 (Pas et al, 1997). Both share a
number of cross-reactive epitopes, contain a similar number of
asparagin-linked carbohydrates, and are sensitive to collagenase.
Furthermore, the LAD-1 molecule is absent in BP180-deficient
generalized atrophic benign epidermolysis bullosa skin and
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keratinocytes (Marinkovich et al, 1997; Pas et al, 1997). As well as
BP180 cross-reactive epitopes, the LAD-1 molecule also contains
unique epitopes. The monoclonal antibodies 123 (Marinkovich
et al, 1996), 97–1, and 97–2 (Zone et al, 1998), and most LAD-
sera (Zone et al, 1990; Pas et al, 1997) label LAD-1 but not BP180.
Recent data by many other groups have confirmed the close
relationship of BP180 and LAD-1. Zone et al (1998) sequenced
the N-terminus and 14 internal peptides accounting for approxi-
mately one-fourth of the 97 kDa fragment of the 120 kDa LAD-
1, and found them all to consist of BP180 sequences. Hirako et al
(1998) purified the bovine 120 kDa molecule and by rotary
shadowing found it to have the same shape as the extracellular
domain of bovine BP180. Ishiko et al (1998) showed by immuno-
electron microscopy that LAD-1 colocalized with the extracellular
domain of BP180, the LAD-1 unique epitope being sandwiched
between the NC16A and the carboxy-terminal domains of BP180,
and suggested that BP180 and LAD-1 may form a complex in vivo.
In this study we have investigated the BP180 high molecular
mass complex observed when unheated protein extracts are run by
SDS-PAGE. We used the temperature sensitivity of this complex
to dissociate it in the second dimension of a two-dimensional SDS-
PAGE and found it to consist of BP180 only. When we analyzed
LAD-1 we found it to exist as a separate trimeric complex but did
not find any evidence for BP180/LAD-1 heterotrimeric complexes.
MATERIALS AND METHODS
Protein extracts
Epidermal extract Fresh human skin was incubated in 1 M NaCl containing
2 mM ethylenediamine tetraacetic acid (EDTA) and 1 mM phenylmethyl-
sulfonyl fluoride at 4°C for 72 h, after which the epidermis could easily
be peeled of the dermis. After three washings with phosphate-buffered
saline the epidermis was then extracted by vortexing it for 2 min at room
temperature in 62.5 mM Tris HCl buffer, pH 6.8, containing 2% SDS,
100 mM dithiothreitol, 2 mM EDTA, and 1 mM Pefablock (Boehringer,
Mannheim, Germany). The remaining epidermal fragments were removed
by centrifugation and the supernatant was stored at –80°C until used.
Cell and medium extracts Human keratinocytes were cultured and extracted
as described previously (Pas et al, 1995). Spent culture medium was stored
at –20°C and, after thawing, processed for extraction as described before
(Pas et al, 1997). The composition of the extraction buffer was as follows:
10 mM Tris HCl buffer, pH 7, containing 2.5% SDS, 5% mercaptoethanol,
1 mM EDTA, and 10% glycerol. Extracts were stored at –80°C.
SDS-PAGE SDS-PAGE was performed on 5% slabgels under reducing
conditions (Laemmli, 1970). For two-dimensional SDS-PAGE, protein
extracts were first separated on 3.9% acrylamide slab gels. A vertical lane
was cut out and equilibrated for 1 h in 10 mM Tris HCl buffer, pH 6.8,
containing 2.5% SDS and 1 mM EDTA. The lane was then sealed in
plastic and incubated for 15 min at 60°C. Next it was placed horizontally
on a 5% acrylamide slabgel and electrophoresis was performed as usual.
Immunoblotting The transfer of the SDS-PAGE patterns to nitrocellu-
lose filters and the immunostaining of the blots have been described before
(Pas et al, 1997). As primary antibodies for detection of BP180 we used
BP patient sera and BP180-specific monoclonal antibody 1A8C (Nishizawa
et al, 1993), which was a kind gift of Dr. K. Owaribe (Nagoya University,
Japan). All incubations and washings were performed with 20 mM Tris
HCl buffer, pH 7.5, containing 500 mm NaCl and 1% low-fat milk powder.
Chemical cross-linking Keratinocytes were grown in 25 cm2 flasks
until subconfluence. The cells were washed twice with phosphate-buffered
saline and then incubated for 10 min at room temperature with 0–2 mM
3.39-dithio(sulfosuccinimidylpropionate) in the presence of 0.1% saponin.
The reaction was terminated by adding 10 mM ammonium chloride to
the flasks. The cells were lyzed with cold water and then extracted with
10 mM Tris HCl buffer, pH 7, containing 2.5% SDS, 1 mM EDTA, and
10% glycerol but no 2-mercaptoethanol. Extracts were stored at –80°C
as usual.
RESULTS
Extraction of BP180 as a trimer Standard immunoblotting of
BP180 results in a protein signal with a molecular weight around
Figure 1. BP180 is present as a high molecular weight complex in
low temperature extracts. Keratinocyte cell extracts were separated by
SDS-PAGE, transferred to a nitrocellulose filter, and stained using BP
patient serum recognizing BP230 and BP180. Although in the heated
extract BP180 is present at its correct molecular weight (lane 1), BP180
runs as a high molecular weight complex in unheated extract (lane 2).
BP230 is not affected by heating. Treating keratinocytes with the chemical
cross-linker 3.39-dithio(sulfosuccinimidylpropionate) before extraction
resulted in a same high molecular weight complex that resisted heating.
Lane 3, heated extract of control cells; lane 4, heated extract of cross-
linked cells. Lanes 3 and 4 were stained with BP180-specific monoclonal
antibody 1A8C.
180 kDa (Fig 1, lane 1). This procedure involves heating the
protein samples in Laemmli sample buffer for 2–5 min at 100°C,
before applying them to the gel. When this step was omitted, and
the keratinocyte cell extracts were subjected to electrophoresis
without prior heating, the final immunoblot did not give a BP180
signal at its usual position. Instead a band was observed at a position
that corresponded with a molecular weight over 500 kDa (Fig 1,
lane 2). When keratinocytes were treated with the chemical cross-
linker 3.39-dithio-sulfosuccinimidylpropionate prior to extraction
with Laemmli sample buffer, a same high molecular band was
visible that resisted heating (Fig 1, lanes 3 and 4). Thus cross-
linking in situ and low temperature extraction apparently result in
the same macromolecular complex.
The protein extracts of the cross-linking experiments were
obtained and electrophoresed in the absence of 2-mercaptoethanol.
Under these conditions BP180 in the control sample also runs as
a monomer after heating (Fig 1, lane 3). Thus apparently the native
protein complex does not contain intermolecular disulfide bridges.
The high molecular band consists of BP180 only The
temperature sensitivity of the low temperature extracted BP180
complex was used to analyze its composition. We developed a
two-dimensional electrophoresis technique in which we dissociated
the complex by heating before running the second dimension (see
Materials and Methods). Immunoblotting confirmed the dissociation
of the high molecular weight complex, BP180 deviated from the
diagonal and ran at its normal 180 kDa position (Fig 2b). Silver
staining demonstrated only one spot with a molecular weight
corresponding to BP180 (Fig 2a).
LAD-1 is also present as a high molecular weight
complex Although the main source of the LAD-1 antigen is
conditioned culture medium, a small quantity is also present in
routinely prepared keratinocyte cell extracts (Pas et al, 1997). When
a two-dimensional immunoblot of concentrated cell extract was
developed with LAD-patient serum the LAD-1 antigen became
visible as a 120 kDa spot that originated from a first dimension
position corresponding to a trimerized LAD-1 molecule (Fig 3a).
When the same blot was reincubated with BP-patient serum
recognizing both LAD-1 and BP180, the 120 kDa spot increased
in intensity and an additional signal at 180 kDa appeared (Fig 3b).
No heterotrimers of BP180 and LAD-1 were observed.
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Figure 2. The BP180 macromolecular complex consists of BP180
only. Two-imensional slabgel electrophoresis and western blotting of cell
extract were performed as described in Materials and Methods. Briefly,
unheated extract was separated in the first dimension, a vertical gel fragment
cut out and heated to dissociate the macromolecular complex, and then
electrophoresed in the second dimension. (a) The two-dimensional gel
was silver stained. On the second dimension position a spot is observed at
the molecular weight of BP180. Note that BP180 is the only abundant
protein to deviate from the diagonal, indicating the relatively strong
resistance of the trimeric conformation to SDS-denaturation. (b) The two-
dimensional immunoblot was stained with monoclonal antibody 1A8C.
BP180 deviates from the first dimension high molecular weight complex
to the monomer position in the second dimension. A colored myosin
marker (204 kDa), mixed in with the substrate, is indicated by an arrow.
Figure 3. BP180 and LAD-1 are present as separate complexes. A
similar two-dimensional immunoblot as in Fig 3 was prepared with the
exception that the substrate was concentrated four times to visualize the
LAD-1 molecule. (a) The immunoblot was stained with LAD-1-specific
LAD patient serum and developed for IgA binding. A single spot at the
correct LAD-1 position is seen deviating from a first dimension high
molecular weight complex. (b) Next bound immunoglobulin was stripped
from the blot by three consecutive washes with 150 mM glycin HCl,
pH 2.7, neutralized by three washes with TBS, stained with BP patient
serum specific for both LAD-1 and BP180, and then developed for IgG
binding. Both LAD-1 and BP180 are now visible as separate spots. The
colored myosin marker is indicated by an arrow.
Temperature-dependent dissociation of the BP180 high
molecular weight complex Cell-extract samples in Laemmli
sample buffer were incubated for 40 min at various temperatures
and the transition of the trimer to the monomer was followed by
SDS-PAGE and immunoblotting. At 31°C only the trimer is
present, but when the temperature is increased the monomeric
form of BP180 steadily appears until at 40°C all BP180 is present
as a monomer (Fig 4a). By intensity scanning of the immunoblot
we calculated the midpoint temperature of the transition from
trimer to monomer under these specific assay conditions to lie
between 35°C and 36°C. A similar dissociation profile could be
obtained with BP180 extracted from human skin (Fig 4b), showing
that the association state of BP180 is identical in skin and cultured
cells under SDS-PAGE conditions.
Temperature-dependent dissociation of high molecular
weight LAD-1 When the above experiment was repeated with
samples of conditioned culture medium, LAD-1 also could be
dissociated to the 120 kDa monomer (Fig 5). An additional lower
molecular weight band was also observed that probably represents
proteolytic degradation. At low temperature the LAD-1 molecule
is present in an high molecular weight form and, like the monomer,
two bands are seen close together that disappear when the amount
of monomer increases. Two unexpected additional bands, with
molecular weights of µ240 and 400 kDa, were also observed,
which appear with increasing preincubation temperature but are
lost in the 100°C heated sample. The same pattern was obtained
Figure 4. Immunoblot showing the temperature-dependent
dissociation of the BP180 high molecular weight complex. Pre-
incubated extracts were subjected to immunoblotting and stained with
monoclonal antibody 1A8C. (a) Cell extract: lane 1, low temperature
extract not preincubated; lanes 2–11, extracts preincubated for 40 min at
31°C (lane 2), 32°C (lane 3), 33°C (lane 4), 34°C (lane 5), 35°C (lane 6),
36°C (lane 7), 37°C (lane 8), 38°C (lane 9), 39°C (lane 10), and 40°C (lane
11); lane 12, extract heated at 100°C for 5 min. (b) Lanes 1 and 2, cell
extract; lanes 3–8, epidermal salt-split skin extract. Lane 1, 5 min 100°C;
lane 2, low temperature extract; lane 3, low temperature extract; lane 4,
30°C preincubated extract; lane 5, 34°C preincubated extract; lane 6, 37°C
preincubated extract; lane 7, 40°C preincubated extract; lane 8, extract
heated 5 min at 100°C. C, high molecular weight complex; M, monomer.
Figure 5. Immunoblot showing the temperature-dependent
dissociation of the LAD-1 high molecular weight complex. Pre-
incubated conditioned medium extracts were preincubated, subjected to
immunoblotting, and stained with LAD-1-specific LAD patient serum.
Lane 1, low temperature extract not preincubated; lanes 2–11, extracts
preincubated for 40 min at 31°C (lane 2), 32°C (lane 3), 33°C (lane 4),
34°C (lane 5), 35°C (lane 6), 36°C (lane 7), 37°C (lane 8), 38°C (lane 9),
39°C (lane 10), and 40°C (lane 11); lane 12, extract heated at 100°C for
5 min. C, high molecular weight complex; M, monomer.
when BP patient serum instead of LAD patient serum was used
for developing the immunoblot (not shown). The origin of these
bands is unknown at present. The band that appears slightly above
the associated LAD-1 might represent the same complex, but with
a different, temperature-induced, folding, thereby running in SDS-
PAGE at a slightly different apparent molecular weight. Another
possibility is that a second unknown molecule, perhaps a ligand of
LAD-1, remains bound to the molecule at intermediate temper-
atures. Silver staining of two-dimensional gels was unsuccessful in
clarifying the nature of the observed pattern by lack of sufficient
protein signal (not shown).
DISCUSSION
Extraction of human keratinocytes and skin with SDS at low
temperature results in a BP180 high molecular weight complex
that runs in SDS-PAGE at a position suggestive of a trimer. The
complex can be heat dissociated in the absence of a reducing agent,
which indicates that it is stabilized by noncovalent forces. Although
SDS dissociates BP180 from its ligands, it is not capable of disrupting
the forces that keep the complex together. This same observation
was made by Balding et al (1997) for the complex formed by the
recombinant BP180 ectodomain and by BP180 extracted from
human epidermis.
The composition of the macromolecular BP180 complex was
analyzed by two-dimensional electrophoresis, in which the temper-
ature sensitivity of the complex was used to dissociate it before
running the second dimension. Silver staining of the resulting gel
showed only BP180 vertical to the position of the high molecular
weight complex. If a second protein had been present in this
complex an additional spot below or above the BP180 spot would
have been expected. The intensity of the BP180 spot was such
that we could safely conclude that no second protein was present.
VOL. 112, NO. 1 JANUARY 1999 MELTING BP180 TRIPLE HELIX 61
These data correspond to the model presented by Hirako et al
(1996) based on the rotary-shadowing data of bovine BP180, which
showed three identical heads in the cytoplasmic domain, and to
the results of Balding et al (1997) for the human BP180 ectodomain
expressed in COS-1 cells, which was also composed of three
identical units. The experiments of Balding furthermore showed
that the information for trimerization is apparently already present
in the ectodomain of the protein.
The linear IgA dermatosis antigen LAD-1 is, at least partly,
homologous to the ectodomain of BP180 and also a collagenous
protein. Therefore we expected the native protein to behave in a
similar manner to BP180 and also to form a trimeric complex. Based
on its homology to the BP180 ectodomain and its ultrastructural
colocalization with BP180, the existence of a BP180/LAD-1
heterotrimer in addition to the BP180 homotrimer could not be
ruled out.
Immunostaining two-dimensional separated cell extract with
LAD and BP patient serum, however, showed two intensive spots
corresponding to BP180 and LAD-1, each originating from their
own first dimension trimeric molecular weights. Thus in cells, both
BP180 and LAD-1 seem to exist as separate homotrimers. Strictly
speaking we cannot, by lack of a sufficient signal in silver staining
analysis of two-dimensional gels, rule out the possibility that the
LAD-1 molecule forms a heterotrimeric complex with a third
molecule, but based on its resemblance to BP180 and its behavior
in the experiments described here, we believe the molecule to be
a homotrimer.
At present the origin of LAD-1 is unknown. It might be a
alternative splicing product of the COL17A1 gene or a proteolytic
cleavage product of BP180 as suggested by Hirako et al (1998)
from their studies on the 120 kDa bovine protein. The data
presented here only show that LAD-1 is present as a separate entity
and is not present as a partly cleaved BP180 residue in a BP180
trimer. If the molecule is produced by cleavage then all three
ectodomains of the BP180 trimer are probably cleaved off together.
The complex is relatively stable at low temperatures and can be
kept in the trimerized form for several days at 4°C. This stability
allows measurements of the kinetics of transition of the complex
to its monomers. Because the process appeared irreversible, probably
because SDS binds to those parts of the protein that become
exposed, thereby inhibiting re-association, only dissociation and not
association constants can be measured. By raising the temperature of
the sample the dissociation can be initiated and the appearance of
the monomer can be monitored by SDS-PAGE. By fixing the
incubation time or temperature, either the dissociation rate or the
dissociation midpoint temperature of the complex can be measured.
In this report we have used a set incubation time (40 min) and
varied the incubation temperature. This way we calculated a
dissociation midpoint temperature T1/2, valid for these specific
incubation conditions, of 35°C –36°C. It should be realized that
this T1/2 is a relative value that depends on the incubation time,
and that shorter or longer incubations would give rise to higher or
lower midpoint temperatures. When the incubation conditions are
standardized, however, these kinetic constants might be used to
compare the stability of recombinant or mutated BP180 complexes
with the wild-type complex.
The collagen nature of the BP180 ectodomain makes it very
probable that this part of the protein is actually folded as a triple-
helix (Giudice et al, 1992; Hirako et al, 1996; Balding et al, 1997).
Therefore it is tempting to speculate that the dissociation of the
trimer to the monomer witnessed here reflects the unwinding of the
BP180 collagen triple-helix to its monomers. If future experiments
would show that BP180 is indeed folded as a helix, it should be
noted that the midpoint temperature calculated here is in no way
related to the midpoint temperature as measured by other established
methods like proteolytic digestion (Bruckner and Prockop, 1980). In
such experiments an equilibrium between unfolding and refolding
exists, which is reflected in the kinetic constants measured. As
already mentioned here we monitor only the dissociation rate of
the complex.
In conclusion, we show here that by low temperature SDS
extraction, BP180 and LAD-1 can be solubilized as separate trimers
and that SDS-PAGE is a simple tool to follow the dissociation to
the monomers.
REFERENCES
Balding SD, Prost C, Diaz LA, Bernard P, Bedane C, Aberdam D, Giudice GJ:
Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180
extracellular domain. J Invest Dermatol 106:141–146, 1996
Balding SD, Diaz LA, Giudice GJA: recombinant form of the human BP180 complex
forms a collagen-like homotrimeric Biochemistry 36:8821–8830, 1997
Bedane C, McMillan JR, Balding SD, et al: Bullous pemphigoid and cicatricial
pemphigoid autoantibodies react with ultrastructurally separable epitopes on
the BP180 ectodomain: evidence that BP180 spans the lamina lucida. J Invest
Dermatol 108:901–907, 1997
Bruckner P, Prockop DJ: Proteolytic enzymes as probes for the triple-helical
conformation of procollagen. Anal Biochem 110:360–368, 1980
Giudice GJ, Emery DJ, Diaz LA: Cloning and primary structural analysis of the
bullous pemphigoid autoantigen BP180. J Invest Dermatol 99:243–250, 1992
Giudice GJ, Emery DJ, Zelickson BD, Anhalt GJ, Liu Z, Diaz LA: Bullous
pemphigoid and herpes gestationis autoantibodies recognize a common non-
collagenous site on the BP180 ectodomain. J Immunol 151:5742–5750, 1993
Hirako Y, Usukura J, Nishizawa Y, Owaribe K: Demonstration of the molecular
shape of BP180, a 180-kDa bullous pemphigoid antigen and its potential for
trimer formation. J Biol Chem 271:13739–13745, 1996
Hirako Y, Usukura J, Uematsu J, Hashimoto T, Kitajima Owaribe K: Cleavage of
BP180, a 180-kDa bullous pemphigoid antigen, yields a 120-kDa collagenous
extracellular peptide J Biol Chem 273:9711–9717, 1998
Ishiko A, Shimizu H, Masunaga T, Yancey KB, Giudice GJ, Zone JJ, Nishikawa T:
97-kDa linear IgA bullous dermatosis antigen localizes in the lamina lucida
between the NC16A and carboxy terminal domains of the 180 kDa bullous
pemphigoid. J Invest Dermatol 111:93–96, 1998
Jonkman MF, De Jong MCJM, Heeres K, et al: 180-kD bullous pemphigoid antigen
(BP180) is deficient in generalized atrophic benign epidermolysis bullosa. J Clin
Invest 95:1345–1352, 1995
Labib RS, Anhalt GJ, Patel HP, Mutasim DF, Diaz LA: Molecular heterogeneity of
the bullous pemphigoid antigens as detected by immunoblotting. J Immunol
136:1231–1235, 1986
Laemmli UK: Cleavage of structural proteins during the assembly of the head of
bacteriophage T4. Nature 227:680–685, 1970
Liu Z, Diaz LA, Troy JL, Taylor AF, Emery DJ, Fairley JA, Giudice GJA: passive
transfer model of the organ-specific autoimmune disease, bullous pemphigoid,
using antibodies generated against the hemidesmosomal antigen, BP180. J Clin
Invest 92:2480–2488, 1993
Marinkovich MP, Taylor TB, Keene DR, Burgeson RE, Zone JJ: LAD-1, the linear
IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament
protein synthesized by epidermal cells. J Invest Dermatol 106:734–738, 1996
Marinkovich MP, Tran HH, Rao SK, et al: LAD-1 is absent in a subset of junctional
epidermolysis bullosa patients. J Invest Dermatol 109:356–359, 1997
McGrath JA, Darling T, Gatalica B, et al: A homozygous deletion mutation in the
gene encoding the 180-kDa bullous pemphigoid antigen (BPAG2) in a family
with generalized atrophic benign epidermolysis bullosa. J Invest Dermatol
106:771–774, 1996
Nishizawa Y, Uematsu J, Owaribe K: HD4, a 180 kDa bullous pemphigoid antigen,
is a major transmembrane glycoprotein of the hemidesmosome. J Biochem
(Tokyo) 113:493–501, 1993
Pas HH, de Jong MC, Jonkman MF, Heeres K, Slijper Pal IJ, van der Meer JB:
Bullous pemphigoid: serum antibody titre and antigen specificity. Exp Dermatol
4:372–376, 1995
Pas HH, Kloosterhuis GJ, Heeres K, van der Meer JB, Jonkman MF: Bullous
pemphigoid and linear IgA dermatosis sera recognize a similar 120-kDa
keratinocyte collagenous glycoprotein with antigenic cross-reactivity to BP180.
J Invest Dermatol 108:423–429, 1997
Scheffer H, Stulp R, Verlind E, et al: Implications of intragenic marker homozygosity
and haplotype sharing in a rare autosomal recessive disorder: The example of
the collagen type XVII locus in generalized atrophic benign epidermolysis
bullosa (GABEB). Hum Genet 100:230–235, 1997
Zillikens D, Rose PA, Balding SD, Liu Z, Olague MM, Diaz LA, Giudice GJ: Tight
clustering of extracellular BP180 epitopes recognized by bullous pemphigoid
autoantibodies. J Invest Dermatol 109:573–579, 1997
Zone JJ, Taylor TB, Kadunce DP, Meyer LJ: Identification of the cutaneous basement
membrane zone antigen and isolation of antibody in linear immunoglobulin
A bullous dermatosis. J Clin Invest 85:812–820, 1990
Zone JJ, Taylor TB, Meyer LJ, Petersen MJ: The 97 kDa linear IgA bullous disease
antigen is identical to a portion of the extracellular domain of the 180 kDa
bullous pemphigoid antigen, BPAg2. J Invest Dermatol 110:207–210, 1998
